FIGURE 2.
In vivo mice study. (A) Groups of cisplatin-sensitive (EMT6/P) and cisplatin-resistant (EMT6/CPR) inoculated mice. Treatments were: WSR extract (100 mg/kg/d) by gavage, a daily 18 h of intermittent fasting (IF) and 6 h of eating or/and cisplatin (5 mg/kg/week) by intraperitoneal injections for 10 days. (B) Scheme for mice experiment (n = 6).